SCHEMBL2845497

SCHEMBL2845497

CCCCCCCCCCCCCCC(N)CC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G1B P04054 1/20 0.58
▸ PLA2G2A P14555 1/20 0.58
▸ OPRM1 P35372 1/20 0.55
▸ S1PR2 O95136 5/20 0.52
▸ S1PR1 P21453 5/20 0.52
▸ S1PR3 Q99500 5/20 0.52
▸ S1PR4 O95977 4/20 0.52
▸ SPHK1 Q9NYA1 2/20 0.50
▸ CYP2D6 P10635 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ GMNN O75496 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ MTOR P42345 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37305 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL37552 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL8980887 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL6898957 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL2223744 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL879073 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL24530563 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL4804084 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL6559841 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL8579056 1.00 PLA2G1B (0.58) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707489-A4 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS INC (US) 1998-07-29 — — EP claimed
EP-0707489-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF Scotgen Biopharmaceuticals, Inc. (US) 1996-04-24 — — EP claimed
WO-1994025053-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS, INC. (US) 1994-11-10 — — WO claimed
CN-115974706-A Long-chain alkyl diisopropanolamine gemini quaternary ammonium salt derivative and preparation method and application thereof 中国日用化学研究院有限公司 2023-04-18 — — CN disclosed
CN-103975003-B Carbon fiber forming blank, moulding material and carbon fibre reinforced composite 东丽株式会社 2017-07-28 — — CN disclosed
US-8877825-B2 Catalyst composition for production of polyurethane resin and method for producing polyurethane resin TOSOH CORPORATION (JP) 2014-11-04 — — US disclosed
US-20100130629-A1 CATALYST COMPOSITION FOR PRODUCTION OF POLYURETHANE RESIN AND METHOD FOR PRODUCING POLYURETHANE RESIN (AS AMENDED) TOSOH CORPORATION (JP) 2010-05-27 — — US disclosed
US-7615221-B2 Compositions and methods for treating cancer ONCOLOGIC, INC. (US) 2009-11-10 — — US disclosed
EP-2050775-A1 CATALYST COMPOSITION FOR POLYURETHANE RESIN PRODUCTION AND METHOD FOR PRODUCING POLYURETHANE RESIN Tosoh Corporation (JP) 2009-04-22 — — EP disclosed
US-6037497-A OXIDIZING TERTIARY AMINE WITH HYDROGEN PEROXIDE IN WATER IN THE PRESENCE OF CARBON DIOXIDE AND AT A GIVEN POINT, TRANSFERRING TO STORAGE CONTAINERS WHERE THE REACTION SLOWLY CONTINUES AT AMBIENT TEMPERATURE; VERY LOW NITROSAMINES ALBEMARLE CORPORATION (US) 2000-03-14 — — US disclosed
US-5536425-A DURABILITY SONY CORPORATION (JP) 1996-07-16 — — US disclosed
US-5453539-A Durability SONY CORPORATION (JP) 1995-09-26 — — US disclosed
EP-0421441-B1 Pantothenic acid derivatives FUJIREBIO KK (JP) 1995-01-25 — — EP disclosed
EP-0519406-A2 Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same SONY CORPORATION (JP) 1992-12-23 — — EP disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 — — US disclosed
Send feedback